Clinical Trial Update: Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and safety evaluation of Androxal in male subjects with impaired hepatic function completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• Androxal (enclomiphene citrate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Secondary Hypogonadism | Phase 1 | Status: COMPLETED